Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/30/20245:36PMBusiness WireLabVantage erwirbt SEIN Infotech South Korea, um das Angebot im Bereich Umwelt-Compliance zu erweitern und das Wachstum in der APAC-Region voranzutreiben
05/30/20245:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVYAvery Dennison Corp
05/30/20245:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFSProvident Financial Services Inc
05/30/20245:35PMPR Newswire (US)Penetration Testing Market size is set to grow by USD 1.92 billion from 2024-2028, Increasing cyberattacks and data breaches boost the market, Technavio
05/30/20245:35PMPR Newswire (US)Mobility-as-a-Service Market size is set to grow by USD 639.92 billion from 2024-2028, Increase in use of smart connected devices boost the market, Technavio
05/30/20245:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMABI MAB
05/30/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBSHCommerce Bancshares Inc
05/30/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WLDNWilldan Group Inc
05/30/20245:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20245:32PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RELIWReliance Global Group Inc
05/30/20245:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
05/30/20245:32PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BHACWFocus Impact BH3 Acquisition Company
05/30/20245:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20245:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20245:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20245:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20245:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/30/20245:32PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BWENBroadwind Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLAPTerran Orbital Corporation
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BWENBroadwind Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BWENBroadwind Inc
05/30/20245:32PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VWEWWVintage Wine Estates Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AGSPlayAGS Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BWENBroadwind Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDNACareDx Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KPTIKaryopharm Therapeutics Inc
05/30/20245:32PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:DMDesktop Metal Inc
05/30/20245:32PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FWBIFirst Wave BioPharma Inc
05/30/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KPTIKaryopharm Therapeutics Inc